Dossiers, industry reports and further studies.
→ All Dossiers
→ All Industry Reports
→ All Toplists
→ All Outlook Reports
→ Study Database We create infographics, animated charts, microsites and publications in your desired corporate design. Add a new visual dimension to your communication & marketing activities. Read more → Infographics Bulletin
Get a Premium Account for unrestrained access.
Benefits of our Premium membership:
| Orphan | Non-orphan | |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
Show further information
Complete Source Details
This statistic displays the average cost per patient using orphan drugs per year in the U.S. from 2012 to 2016. In 2014, patients using orphan drugs accumulated average yearly costs of 137,545 U.S. dollars. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.
+
+All Information
in one Presentation
Everything On "Orphan drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Currently, Statista provides more than 1 million statistics. 93 percent (all Premium content) are exclusively accessible via our professional accounts.
As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.
$588*
per year
* All products require an annual contract.
Prices do not include sales tax
(New York residents only).
Register in seconds and access exclusive features.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Exclusive Statista studies on market-relevant topics: 
